News
A vaccine developed by the University of Oxford to protect people from a deadly virus has been granted support by Europe’s medicines regulator.
GSK RSV vaccine Arexvy accepted for regulatory review by EMA to expand use in adults 18 years, older
London: GSK plc has announced that the European Medicines Agency (EMA) has accepted the company's regulatory application to ...
A vaccine developed by the University of Oxford to protect people from a deadly virus has been granted support by Europe’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback